Transforming Perspectives in Cardiac Cell Therapy: Hypothesis and Commentary Following Updated Results of a Pilot Study Investigating Very Long-Term Clinical Outcomes in Severe AMI Patients Following Trans-Epicardial Injection of Peripheral Blood CD34⁺ Cells.

"Declarations Ethical StatementAll patients gave their written informed consent. The study was launched after the approval of the “Comité de Protection des Personnes (CPP) Est-4 – Strasbourg”, and the authorization of the French Health Regulatory Agency (ANSM).The study was conducted according to the Guidelines of the Declaration of Helsinki. GrantsThe pilot study was supported by a grant of the French Ministry of Health. Conflict of InterestP.H. is staff member and stakeholder of CellProthera. Conflict of Interest P.H. is staff member and stakeholder of CellProthera."

"Declarations: Ethical StatementAll patients gave their written informed consent. The study was launched after the approval of the “Comité de Protection des Personnes (CPP) Est-4 – Strasbourg”, and the authorization of the French Health Regulatory Agency (ANSM).The study was conducted according to the Guidelines of the Declaration of Helsinki.: GrantsThe pilot study was supported by a grant of the French Ministry of Health.: Conflict of InterestP.H. is staff member and stakeholder of CellProthera. Grants: The pilot study was supported by a grant of the French Ministry of Health."